|
rs113488022
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Although, in IHC studies, nuclear BRAF V600E (VE1) protein expression was found in 14 (15%) of the analyzed cases: nine of 28 (32%) cases of pleomorphic adenoma, three of five (60%) cases of ductal carcinoma, one of nine (11%) case of mucoepidermoid carcinoma, and in one of five (20%) case of carcinoma ex pleomorphic adenoma.
|
27682157 |
2017 |
|
rs121913377
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Although, in IHC studies, nuclear BRAF V600E (VE1) protein expression was found in 14 (15%) of the analyzed cases: nine of 28 (32%) cases of pleomorphic adenoma, three of five (60%) cases of ductal carcinoma, one of nine (11%) case of mucoepidermoid carcinoma, and in one of five (20%) case of carcinoma ex pleomorphic adenoma.
|
27682157 |
2017 |
|
rs113488022
|
|
|
0.020 |
GeneticVariation |
BEFREE |
We employed the sensitive and quantitative Allele-specific Competitive Blocker PCR approach to characterize mutant cancer subpopulations in ductal carcinomas (DCs), examining five specific hotspot point mutations (PIK3CA H1047R, KRAS G12D, KRAS G12V, HRAS G12D, and BRAF V600E).
|
27108388 |
2016 |
|
rs121913377
|
|
|
0.020 |
GeneticVariation |
BEFREE |
We employed the sensitive and quantitative Allele-specific Competitive Blocker PCR approach to characterize mutant cancer subpopulations in ductal carcinomas (DCs), examining five specific hotspot point mutations (PIK3CA H1047R, KRAS G12D, KRAS G12V, HRAS G12D, and BRAF V600E).
|
27108388 |
2016 |
|
rs121913529
|
|
|
0.020 |
GeneticVariation |
BEFREE |
We employed the sensitive and quantitative Allele-specific Competitive Blocker PCR approach to characterize mutant cancer subpopulations in ductal carcinomas (DCs), examining five specific hotspot point mutations (PIK3CA H1047R, KRAS G12D, KRAS G12V, HRAS G12D, and BRAF V600E).
|
27108388 |
2016 |
|
rs121913529
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Here we present the first formal evidence of the shared and independent ability of basal cells and luminal progenitors, isolated from normal human mammary tissue and transduced with a single oncogene (KRAS(G12D)), to produce serially transplantable, polyclonal, invasive ductal carcinomas within 8 weeks of being introduced either subrenally or subcutaneously into immunodeficient mice.
|
26633636 |
2015 |
|
rs104894230
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We employed the sensitive and quantitative Allele-specific Competitive Blocker PCR approach to characterize mutant cancer subpopulations in ductal carcinomas (DCs), examining five specific hotspot point mutations (PIK3CA H1047R, KRAS G12D, KRAS G12V, HRAS G12D, and BRAF V600E).
|
27108388 |
2016 |
|
rs12190287
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Stratified analyses based on pathological type indicated that TCF21 rs12190287 polymorphism was only associated with the reduced risk of infiltrative ductal carcinoma.
|
27270650 |
2016 |
|
rs121913279
|
|
|
0.010 |
GeneticVariation |
BEFREE |
However, the PIK3CA H1047R mutant fraction distributions for normal breast tissues and DCs were similar.
|
27108388 |
2016 |
|
rs727503094
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We employed the sensitive and quantitative Allele-specific Competitive Blocker PCR approach to characterize mutant cancer subpopulations in ductal carcinomas (DCs), examining five specific hotspot point mutations (PIK3CA H1047R, KRAS G12D, KRAS G12V, HRAS G12D, and BRAF V600E).
|
27108388 |
2016 |
|
rs1799983
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In addition, stratified analyses based on pathological type showed that eNOS 894G>T polymorphism was only associated with the risk of infiltrative ductal carcinoma.
|
26131841 |
2015 |
|
rs7874234
|
|
|
0.010 |
GeneticVariation |
BEFREE |
This study found that for TSC1 rs7874234, TT variant carriers had a 9-year later age at diagnosis of estrogen receptor positive (ER+), but not ER-, ductal carcinomas (P = 0.0049).
|
20658316 |
2011 |
|
rs25487
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The association between XRCC1-Arg399Gln polymorphism and ductal carcinoma was statistically significant (P = 0.02).
|
18752184 |
2008 |
|
rs759412116
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The association between XRCC1-Arg399Gln polymorphism and ductal carcinoma was statistically significant (P = 0.02).
|
18752184 |
2008 |